OraSure Technologies (OSUR)

OraSure is best known for diagnostic testing platforms and oral fluid collection technologies. Its product portfolio has included tests and collection devices related to infectious disease, sexual health, molecular sampling and public health applications. The company’s technologies support both direct diagnostic testing and the collection, stabilization and transport of biological samples for analysis by laboratories and healthcare organizations.

The business operates at the intersection of diagnostics, population health and healthcare data workflows. By enabling easier sample collection and broader testing access, OraSure serves customers such as healthcare providers, laboratories, government agencies, public health programs, employers and research organizations. Its products can be relevant in settings where rapid testing, at-home collection or large-scale screening programs are needed.

Revenue is primarily generated from the sale of diagnostic products and sample management solutions, with the United States representing its largest market. OraSure’s results can be influenced by testing demand, regulatory approvals, public health funding, product mix and the competitive landscape for diagnostics and laboratory services.

For investors, OSUR represents exposure to a specialized medical technology company focused on practical tools that expand access to testing and sample collection. Its long-term positioning depends on innovation, manufacturing execution, regulatory compliance and the ability to adapt its product portfolio to changing healthcare and public health priorities.